Integra LifeSciences Holdings Corporation (IART)

IART Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,624	1,611	1,542	1,558	1,542	1,372
Revenue Growth (YoY)	6.19%	4.47%	-1.03%	0.99%	12.43%	-9.60%
Cost of Revenue	669.89	651.41	593.66	587.36	597.81	520.83
Gross Profit	954.41	959.12	947.92	970.31	944.64	851.03
Selling, General & Admin	669.9	665.53	592.64	616.32	637.45	594.53
Research & Development	96.72	97.43	82.84	101.19	93.05	77.38
Operating Expenses	781.46	777.15	687.86	731.39	744.66	699.66
Operating Income	172.95	181.98	260.06	238.92	199.98	151.37
Interest Expense	-75.82	-70.63	-51.38	-49.59	-50.4	-71.58
Interest & Investment Income	19.42	20.04	17.2	11.92	6.74	9.3
Currency Exchange Gain (Loss)	-4.48	35.23	-35.75	3.3	-	-1.6
Other Non Operating Income (Expenses)	9.7	-30.98	38.6	8.71	19.31	6.03
EBT Excluding Unusual Items	121.77	135.63	228.74	213.25	175.63	93.52
Merger & Restructuring Charges	-10.55	-4.95	-1.05	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	0.64	41.8	-
Asset Writedown	-4.64	-11.7	-	-	-2.75	-
Other Unusual Items	-149.63	-137.22	-146.62	-	-	-
Pretax Income	-43.04	-18.24	81.07	213.89	214.68	93.52
Income Tax Expense	-14.09	-11.29	13.33	33.34	45.6	-40.37
Earnings From Continuing Operations	-28.96	-6.94	67.74	180.55	169.08	133.89
Net Income	-28.96	-6.94	67.74	180.55	169.08	133.89
Net Income to Common	-28.96	-6.94	67.74	180.55	169.08	133.89
Net Income Growth	-	-	-62.48%	6.79%	26.28%	166.71%
Shares Outstanding (Basic)	77	77	80	83	85	85
Shares Outstanding (Diluted)	77	77	80	84	85	85
Shares Change (YoY)	-3.15%	-4.14%	-3.81%	-2.30%	0.30%	-1.46%
EPS (Basic)	-0.38	-0.09	0.85	2.18	2.00	1.58
EPS (Diluted)	-0.38	-0.09	0.84	2.16	1.98	1.57
EPS Growth	-	-	-61.11%	9.09%	26.11%	170.69%
Free Cash Flow	-15.5	24.96	73.09	222.13	264.41	164.94
Free Cash Flow Per Share	-0.20	0.32	0.91	2.66	3.09	1.94
Gross Margin	58.76%	59.55%	61.49%	62.29%	61.24%	62.03%
Operating Margin	10.65%	11.30%	16.87%	15.34%	12.96%	11.03%
Profit Margin	-1.78%	-0.43%	4.39%	11.59%	10.96%	9.76%
Free Cash Flow Margin	-0.95%	1.55%	4.74%	14.26%	17.14%	12.02%
EBITDA	320.47	322.87	383.57	357.22	319.82	267.4
EBITDA Margin	19.73%	20.05%	24.88%	22.93%	20.73%	19.49%
D&A For EBITDA	147.52	140.89	123.51	118.3	119.84	116.03
EBIT	172.95	181.98	260.06	238.92	199.98	151.37
EBIT Margin	10.65%	11.30%	16.87%	15.34%	12.96%	11.03%
Effective Tax Rate	-	-	16.44%	15.59%	21.24%	-

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q